Processa Pharmaceuticals, Inc.
PCSA· Nasdaq
PCSAProcessa Pharmaceuticals, Inc.
Filed May 13, 2021 · 10-Q · 43 days after period end · 0001493152-21-011311
| Metric | Q1 2021 | Q1 2020 | Q1 2019 | Q1 2018 |
|---|---|---|---|---|
| Net Income | -$2.10M | -$874.34K | -$750.83K | -$1.10M |
| EPS Diluted | -$0.14 | -$0.16 | -$0.14 | -$0.03 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Processa Pharmaceuticals, Inc. · CIK 1533743 · Engraved from SEC EDGAR
ended Mar 31, 2021 · filed May 13, 2021 · 43 d after period end
